Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients

被引：0
|
作者：
Christine Robin
François Hémery
Christel Dindorf
Julien Thillard
Ludovic Cabanne
Rabah Redjoul
Florence Beckerich
Christophe Rodriguez
Cécile Pautas
Andrea Toma
Sébastien Maury
Isabelle Durand-Zaleski
Catherine Cordonnier
机构：
[1] Assistance Publique-Hopitaux de Paris (APHP),Department of Hematology
[2] Henri Mondor Teaching Hospital,Department of Medical Information
[3] University Paris-Est Créteil (UPEC),Department of Virology, and INSERM U955 Team 18
[4] APHP,Department of Public Health
[5] Henri Mondor Teaching Hospital,undefined
[6] URC-Eco APHP ECEVE UMRS 1123,undefined
[7] APHP,undefined
[8] Henri Mondor Teaching Hospital,undefined
[9] APHP,undefined
[10] Henri Mondor Teaching Hospital,undefined
来源：
BMC Infectious Diseases | / 17卷
关键词：
Allogeneic stem cell transplantation; CMV infection; Antivirals; Costs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] CMV infection and disease in 100 allogeneic BMT patients: From no prophylaxis to preemptive treatment
    Bron, D
    Meuleman, N
    Debruyne, JM
    Maerevoet, M
    Rizopoulo, H
    Stryckmans, P
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 208 - 209
  • [32] Clinical Outcome Associated with Cytomegalovirus (CMV) Infection/Disease in CMV-Seropositive Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation
    De latour, Regis Peffault
    Chevallier, Patrice
    Blaise, Didier
    Clement, Aurore
    Allavoine, Thierry
    Tadmouri, Abir
    Blomkvist, Josefin
    Duhamel, Alain
    Yakoub-Agha, Ibrahim
    [J]. BLOOD, 2018, 132
  • [33] Prognostic Impact of Recipient and Donor CMV Serostatus in Acute Leukemia Patients After Allogeneic Stem Cell Transplantation At the Era of Preemptive Therapy.
    Schmidt-Hieber, Martin
    Labopin, Myriam
    Beelen, Dietrich
    Volin, Liisa
    Ehninger, Gerhard
    Finke, Juergen
    Socie, Gerard
    Schwerdtfeger, Rainer
    Kroeger, Nicolaus
    Ganser, Arnold
    Niederwieser, Dietger
    Feldmann, Ulrike
    Mueller, Carlheinz
    Polge, Emanuelle
    Blau, Igor Wolfgang
    Mohty, Mohamad
    [J]. BLOOD, 2012, 120 (21)
  • [34] Human cytomegalovirus DNAemia and preemptive treatment of CMV infection in children after hematopoietic stem-cell transplantation: Is any question settled?
    Cesaro, Simone
    Abate, Davide
    Mengoli, Carlo
    [J]. BLOOD, 2008, 111 (08) : 4419 - 4419
  • [35] Risk for CMV disease in patients receiving PCR-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.
    Hebart, H
    Brugger, W
    Grigoleit, U
    Schaefer, HJ
    Kanz, L
    Einsele, H
    [J]. BLOOD, 2000, 96 (11) : 190A - 190A
  • [36] CMV genotypes in patiens after allogeneic haematopoietic stem cell transplantation
    Hubacek, P.
    Javornicka, T.
    Sumova, J.
    Keslova, P.
    Kouba, M.
    Zajac, M.
    Markova-Stastna, M.
    Sedlacek, P.
    Cetkovsk, P.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S410 - S411
  • [37] Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study
    Chemaly, Roy F.
    El Haddad, Lynn
    Winston, Drew J.
    Rowley, Scott D.
    Mulane, Kathleen M.
    Chandrasekar, Pranatharthi
    Avery, Robin K.
    Hari, Parameswaran
    Peggs, Karl S.
    Kumar, Deepali
    Nath, Rajneesh
    Ljungman, Per
    Mossad, Sherif B.
    Dadwal, Sanjeet S.
    Blanchard, Ted
    Shah, Dimpy P.
    Jiang, Ying
    Ariza-Heredia, Ella
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : 2365 - 2374
  • [38] Extension of CMV Prophylaxis possible after allogeneic Stem Cell Transplantation
    Freyer, Martina
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (02) : 127 - 127
  • [39] Extension of CMV prophylaxis possible after allogeneic stem cell transplantation
    Freyer, Martina
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (04) : 162 - 162
  • [40] Cytotect®CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study
    Tamim Alsuliman
    Caroline Kitel
    Rémy Dulery
    Thierry Guillaume
    Fabrice Larosa
    Jérôme Cornillon
    Helene Labussière-Wallet
    Clémence Médiavilla
    Stéphanie Belaiche
    Jeremy Delage
    Sophie Alain
    Ibrahim Yakoub-Agha
    [J]. Bone Marrow Transplantation, 2018, 53 : 1328 - 1335
12345